INVO Bioscience, Inc. (NASDAQ:INVO) Short Interest Down 72.6% in June

INVO Bioscience, Inc. (NASDAQ:INVO) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 20,700 shares, a decrease of 72.6% from the June 15th total of 75,600 shares. Based on an average trading volume of 3,800,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.6% of the company’s stock are sold short.

INVO Bioscience Trading Up 2.7 %

Shares of INVO Bioscience stock traded up $0.02 during trading hours on Thursday, reaching $0.79. The company’s stock had a trading volume of 37,901 shares, compared to its average volume of 1,884,887. The company’s 50 day simple moving average is $0.89 and its 200 day simple moving average is $1.01. INVO Bioscience has a one year low of $0.50 and a one year high of $7.20.

INVO Bioscience (NASDAQ:INVO) last posted its quarterly earnings results on Wednesday, May 15th. The company reported ($0.42) earnings per share (EPS) for the quarter. The firm had revenue of $1.58 million for the quarter.

About INVO Bioscience

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.